Evaluation of the Effectiveness of Therapy for Patients With Covid-19 Using Food Supplements Viusid + Asbrip
Status:
Completed
Trial end date:
2021-09-15
Target enrollment:
Participant gender:
Summary
This is a two-arm, randomized, open label, monocenter, controlled study to evaluate the
safety and efficacy of Viusid plus Asbrip in patients with mild and moderate symptoms of
respiratory illness caused by Coronavirus 2019 infection.